LUMIQO is an AI-powered clinical research assistant designed to help trial sites identify, grade, document, and report adverse events in oncology, hematology, and rare disease clinical trials.

We built LUMIQO because adverse event data collection is still one of the most manual processes in clinical research. Coordinators enter the same data into multiple systems per study. CTCAE grading varies across sites. Expedited reporting timelines leave little room for error. And the tools that exist often add to the burden rather than reduce it.

LUMIQO is designed to work inside the clinician’s existing EHR workflow. Our AI surfaces adverse events from clinical notes, suggests CTCAE grades, flags potential SAEs, and supports documentation with a human-in-the-loop approach that keeps the clinician in control. Not alongside the workflow. Inside it.

We serve pharmaceutical companies, biotechs, CROs, NCI-designated cancer centers, academic medical centers, and community hospitals running clinical trials. The people we support every day are principal investigators, study coordinators, research nurses, and clinical operations teams.

Patient safety and the protection of PHI are the foundation of our technology. Responsible AI and strong governance guide every decision we make.

At LUMIQO, we are turning the corners in clinical research operations. 

Learn more at lumiqo.com

LUMIQO

Org chart

Teams

Offices